JP2023529502A5 - - Google Patents

Info

Publication number
JP2023529502A5
JP2023529502A5 JP2022577105A JP2022577105A JP2023529502A5 JP 2023529502 A5 JP2023529502 A5 JP 2023529502A5 JP 2022577105 A JP2022577105 A JP 2022577105A JP 2022577105 A JP2022577105 A JP 2022577105A JP 2023529502 A5 JP2023529502 A5 JP 2023529502A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
patient
composition according
compound
optionally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022577105A
Other languages
English (en)
Japanese (ja)
Other versions
JP7832128B2 (ja
JP2023529502A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/037230 external-priority patent/WO2021257456A1/en
Publication of JP2023529502A publication Critical patent/JP2023529502A/ja
Publication of JP2023529502A5 publication Critical patent/JP2023529502A5/ja
Priority to JP2025252108A priority Critical patent/JP2026048841A/ja
Application granted granted Critical
Publication of JP7832128B2 publication Critical patent/JP7832128B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022577105A 2020-06-15 2021-06-14 心房機能不全の治療 Active JP7832128B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025252108A JP2026048841A (ja) 2020-06-15 2025-12-16 心房機能不全の治療

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063039438P 2020-06-15 2020-06-15
US63/039,438 2020-06-15
US202063042512P 2020-06-22 2020-06-22
US63/042,512 2020-06-22
PCT/US2021/037230 WO2021257456A1 (en) 2020-06-15 2021-06-14 Treatment of atrial dysfunction

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025252108A Division JP2026048841A (ja) 2020-06-15 2025-12-16 心房機能不全の治療

Publications (3)

Publication Number Publication Date
JP2023529502A JP2023529502A (ja) 2023-07-10
JP2023529502A5 true JP2023529502A5 (enExample) 2024-06-24
JP7832128B2 JP7832128B2 (ja) 2026-03-17

Family

ID=76845320

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022577105A Active JP7832128B2 (ja) 2020-06-15 2021-06-14 心房機能不全の治療
JP2025252108A Pending JP2026048841A (ja) 2020-06-15 2025-12-16 心房機能不全の治療

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025252108A Pending JP2026048841A (ja) 2020-06-15 2025-12-16 心房機能不全の治療

Country Status (13)

Country Link
US (1) US20230233545A1 (enExample)
EP (1) EP4164644A1 (enExample)
JP (2) JP7832128B2 (enExample)
KR (1) KR20230024977A (enExample)
CN (1) CN116056703A (enExample)
AU (1) AU2021293817A1 (enExample)
BR (1) BR112022025551A2 (enExample)
CA (1) CA3180943A1 (enExample)
CL (1) CL2022003548A1 (enExample)
IL (1) IL298885A (enExample)
MX (1) MX2022015488A (enExample)
TW (1) TW202214241A (enExample)
WO (1) WO2021257456A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11759640B2 (en) * 2022-01-07 2023-09-19 Xyra, Llc Methods for reducing the risk of strokes by pharmacotherapy to reduce the number and duration of atrial fibrillations
CN116082326B (zh) * 2022-12-16 2024-12-27 药康众拓(江苏)医药科技有限公司北京分公司 一种氘代吡唑磺酰甲基-哌啶异噁唑脲类化合物及其用途
CN119157623A (zh) * 2023-12-12 2024-12-20 成都迈格因科技有限公司 一种经导管心脏射频消融的蒸汽爆破安全预警和控制系统
CN117815534A (zh) * 2023-12-12 2024-04-05 苏州晟智医疗科技有限公司 反搏辅助装置、计算设备、存储介质及反搏系统
CN118304374A (zh) * 2024-04-01 2024-07-09 山东省中医药研究院附属医院 一种组合物在制备治疗心动过速和/或瓣膜反流药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH12021553074A1 (en) * 2015-01-22 2023-03-06 Myokardia Inc 4-methylsulfonyl-substituted piperidine urea compounds for the treatment of dilated cardiomyopathy (dcm)
US10758525B2 (en) * 2015-01-22 2020-09-01 MyoKardia, Inc. 4-methylsulfonyl-substituted piperidine urea compounds
JP2020519628A (ja) * 2017-05-10 2020-07-02 インカーダ セラピューティクス, インコーポレイテッド 肺投与によって心臓の状態を処置するための単位用量、エアロゾル、キットおよび方法
LT3645002T (lt) * 2017-06-30 2025-02-10 Amgen Inc. Širdies nepakankamumo gydymo būdas širdies sarkomerų aktyvatoriais
CA3138080A1 (en) * 2019-05-19 2020-11-26 Jean-Francois TAMBY Treatment of systolic dysfunction and heart failure with reduced ejection fraction with the compound(r)-4-(1-((3-(difluoromethyl)-1-methyl-1h-pyrazol-4-yl)sulfonyl)-1-fluoroethyl) n-(isoxazol-3-yl)piperidine-1-carboxamid

Similar Documents

Publication Publication Date Title
Kishon et al. Mitral valve operation in postinfarction rupture of a papillary muscle: immediate results and long-term follow-up of 22 patients
Bocchi et al. Clinical outcome after left ventricular surgical remodeling in patients with idiopathic dilated cardiomyopathy referred for heart transplantation: short-term results
EP2749282B1 (en) Method of treating atrial fibrillation
Christakis et al. Predictors of operative survival after valve replacement
JP2022535195A5 (enExample)
JP2025106475A5 (enExample)
JP2025523921A (ja) 非閉塞性肥大型心筋症を治療するための方法
Sezai et al. Efficacy of Low-Dose Continuous Infusion of α-Human Atrial Natriuretic Peptide (hANP) During Cardiac Surgery Possibility of Postoperative Left Ventricular Remodeling Effect
Miyazaki et al. Reversible left ventricular dysfunction" takotsubo" cardiomyopathy associated with hyperthyroidism
Mantziari et al. Cardiac resynchronization therapy for critically ill patients with left ventricular systolic dysfunction
US11911384B2 (en) Vasodilators for treatment of heart failure
Musat et al. Pathophysiology of hypertrophic cardiomyopathy determines its medical treatment
Magalhães et al. Oral triiodothyronine for the prevention of thyroid hormone reduction in adult valvular cardiac surgery
Morisco et al. Lisinopril in the treatment of congestive heart failure in elderly patients: comparison versus captopril
Kumar et al. Early and midterm results of extended septal myectomy: Indian experience
Berger et al. State-of–the-Art Management of Hypertrophic Cardiomyopathy in Children
BEZERRA et al. BRADYCARDIA-TACHYCARDIA SYNDROME IN A POST-OPERATIVE CARDIAC SURGERY PATIENT
WO2012020377A1 (en) Use of dronedarone for the preparation of a medicament for rhythm- and rate-controlling in patients with atrial fibrillation
Kokaji et al. Efficacy of endoventricular circular patch plasty: will this procedure improve the prognosis of patients with ischemic cardiomyopathy?
Martinez et al. Intractable, Life-Threatening Cardiac Arrhythmias Following MCS
Hosokawa et al. Impact of percutaneous transluminal septal myocardial ablation on refractory paroxysmal atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy
Novikova et al. Disease-Modifying Therapy of Chronic Heart Failure on the Background of Heart Rhythm and Conductivity Disorders (Clinical Case)
Choo et al. Amiodarone rescue therapy for severe decompensated Heart failure initially unsuitable for β-blockers
Maron et al. Surviving Malignant Hypertrophic Cardiomyopathy with All Major Complications in a Single Patient
AU2014274638B2 (en) Method of treating atrial fibrillation